NO20050979L - Caninus respiratorisk coronavirus (CRCV) spike protein, polymerase og hemagglutinin/esterase - Google Patents
Caninus respiratorisk coronavirus (CRCV) spike protein, polymerase og hemagglutinin/esteraseInfo
- Publication number
- NO20050979L NO20050979L NO20050979A NO20050979A NO20050979L NO 20050979 L NO20050979 L NO 20050979L NO 20050979 A NO20050979 A NO 20050979A NO 20050979 A NO20050979 A NO 20050979A NO 20050979 L NO20050979 L NO 20050979L
- Authority
- NO
- Norway
- Prior art keywords
- crcv
- coronavirus
- hemagglutinin
- polymerase
- esterase
- Prior art date
Links
- 108090000371 Esterases Proteins 0.000 title abstract 2
- 101710154606 Hemagglutinin Proteins 0.000 title abstract 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 title abstract 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 title abstract 2
- 101710176177 Protein A56 Proteins 0.000 title abstract 2
- 239000000185 hemagglutinin Substances 0.000 title abstract 2
- 241000711573 Coronaviridae Species 0.000 title 1
- 229940096437 Protein S Drugs 0.000 title 1
- 101710198474 Spike protein Proteins 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
- 241001594994 Canine respiratory coronavirus Species 0.000 abstract 3
- 241000711443 Bovine coronavirus Species 0.000 abstract 1
- 241000711506 Canine coronavirus Species 0.000 abstract 1
- 241000282465 Canis Species 0.000 abstract 1
- 241000282472 Canis lupus familiaris Species 0.000 abstract 1
- 241001428935 Human coronavirus OC43 Species 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Glass Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0217434.0A GB0217434D0 (en) | 2002-07-27 | 2002-07-27 | Biological material |
| PCT/GB2003/002832 WO2004011651A1 (fr) | 2002-07-27 | 2003-07-01 | Proteine a pointes du coronavirus respiratoire canin (crcv), polymerase et hemagglutinine/esterase correspondantes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20050979D0 NO20050979D0 (no) | 2005-02-23 |
| NO20050979L true NO20050979L (no) | 2005-04-25 |
Family
ID=9941223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20050979A NO20050979L (no) | 2002-07-27 | 2005-02-23 | Caninus respiratorisk coronavirus (CRCV) spike protein, polymerase og hemagglutinin/esterase |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7776340B2 (fr) |
| EP (2) | EP2182066A3 (fr) |
| JP (1) | JP4644486B2 (fr) |
| AT (1) | ATE491793T1 (fr) |
| AU (1) | AU2003244822B2 (fr) |
| CA (2) | CA2727782C (fr) |
| CY (1) | CY1111655T1 (fr) |
| DE (1) | DE60335374D1 (fr) |
| DK (1) | DK1525313T3 (fr) |
| ES (1) | ES2384445T3 (fr) |
| GB (1) | GB0217434D0 (fr) |
| MX (1) | MXPA05001098A (fr) |
| NO (1) | NO20050979L (fr) |
| NZ (2) | NZ537778A (fr) |
| PT (1) | PT1525313E (fr) |
| SI (1) | SI1525313T1 (fr) |
| WO (1) | WO2004011651A1 (fr) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7226739B2 (en) | 2001-03-02 | 2007-06-05 | Isis Pharmaceuticals, Inc | Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations |
| US7666588B2 (en) | 2001-03-02 | 2010-02-23 | Ibis Biosciences, Inc. | Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy |
| US20040121313A1 (en) | 2002-12-06 | 2004-06-24 | Ecker David J. | Methods for rapid detection and identification of bioagents in organs for transplantation |
| US20030027135A1 (en) | 2001-03-02 | 2003-02-06 | Ecker David J. | Method for rapid detection and identification of bioagents |
| US8073627B2 (en) | 2001-06-26 | 2011-12-06 | Ibis Biosciences, Inc. | System for indentification of pathogens |
| US7217510B2 (en) | 2001-06-26 | 2007-05-15 | Isis Pharmaceuticals, Inc. | Methods for providing bacterial bioagent characterizing information |
| JP2006516193A (ja) | 2002-12-06 | 2006-06-29 | アイシス・ファーマシューティカルス・インコーポレーテッド | ヒトおよび動物における病原体の迅速な同定方法 |
| US8057993B2 (en) | 2003-04-26 | 2011-11-15 | Ibis Biosciences, Inc. | Methods for identification of coronaviruses |
| US7964343B2 (en) | 2003-05-13 | 2011-06-21 | Ibis Biosciences, Inc. | Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| US8158354B2 (en) | 2003-05-13 | 2012-04-17 | Ibis Biosciences, Inc. | Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| GB0315323D0 (en) * | 2003-07-01 | 2003-08-06 | Royal Veterinary College | Vaccine composition |
| US9023366B2 (en) | 2003-07-01 | 2015-05-05 | The Royal Veterinary College | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) |
| US8546082B2 (en) | 2003-09-11 | 2013-10-01 | Ibis Biosciences, Inc. | Methods for identification of sepsis-causing bacteria |
| US8097416B2 (en) | 2003-09-11 | 2012-01-17 | Ibis Biosciences, Inc. | Methods for identification of sepsis-causing bacteria |
| US8394945B2 (en) | 2003-09-11 | 2013-03-12 | Ibis Biosciences, Inc. | Compositions for use in identification of bacteria |
| US7666592B2 (en) | 2004-02-18 | 2010-02-23 | Ibis Biosciences, Inc. | Methods for concurrent identification and quantification of an unknown bioagent |
| WO2006076007A2 (fr) * | 2004-04-22 | 2006-07-20 | Vanderbilt University | Procedes de detection d'infections coronavirus |
| ES2641832T3 (es) | 2004-05-24 | 2017-11-14 | Ibis Biosciences, Inc. | Espectrometría de masas con filtración de iones selectiva por establecimiento de umbrales digitales |
| US20050266411A1 (en) | 2004-05-25 | 2005-12-01 | Hofstadler Steven A | Methods for rapid forensic analysis of mitochondrial DNA |
| US7811753B2 (en) | 2004-07-14 | 2010-10-12 | Ibis Biosciences, Inc. | Methods for repairing degraded DNA |
| WO2006135400A2 (fr) | 2004-08-24 | 2006-12-21 | Isis Pharmaceuticals, Inc. | Procedes pour l'identification rapide d'organismes recombinants |
| US20060205040A1 (en) | 2005-03-03 | 2006-09-14 | Rangarajan Sampath | Compositions for use in identification of adventitious viruses |
| US8084207B2 (en) | 2005-03-03 | 2011-12-27 | Ibis Bioscience, Inc. | Compositions for use in identification of papillomavirus |
| WO2007014045A2 (fr) | 2005-07-21 | 2007-02-01 | Isis Pharmaceuticals, Inc. | Procede pour l'identification et la quantification rapide de variants d'acide nucleique |
| KR20110126726A (ko) | 2005-10-07 | 2011-11-23 | 화이자 프로덕츠 인코포레이티드 | 개과 동물의 인플루엔자의 치료를 위한 백신 및 방법 |
| ES2355702T3 (es) * | 2005-10-26 | 2011-03-30 | Canio Buonavoglia | Coronavirus canino pantrópico. |
| US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
| EP2064332B1 (fr) | 2006-09-14 | 2012-07-18 | Ibis Biosciences, Inc. | Procédé d'amplification ciblée de génome entier pour l'identification d'agents pathogènes |
| US8871471B2 (en) | 2007-02-23 | 2014-10-28 | Ibis Biosciences, Inc. | Methods for rapid forensic DNA analysis |
| US9598724B2 (en) | 2007-06-01 | 2017-03-21 | Ibis Biosciences, Inc. | Methods and compositions for multiple displacement amplification of nucleic acids |
| US8148163B2 (en) | 2008-09-16 | 2012-04-03 | Ibis Biosciences, Inc. | Sample processing units, systems, and related methods |
| EP2344893B1 (fr) | 2008-09-16 | 2014-10-15 | Ibis Biosciences, Inc. | Systèmes et procédés de manipulation de microplaques |
| WO2010033599A2 (fr) | 2008-09-16 | 2010-03-25 | Ibis Biosciences, Inc. | Cartouches de mélange, postes de mélange et kits, systèmes et procédés associés |
| US8158936B2 (en) | 2009-02-12 | 2012-04-17 | Ibis Biosciences, Inc. | Ionization probe assemblies |
| WO2011008971A1 (fr) | 2009-07-17 | 2011-01-20 | Ibis Biosciences, Inc. | Appareil de levage et de montage |
| WO2011008972A1 (fr) | 2009-07-17 | 2011-01-20 | Ibis Biosciences, Inc. | Systèmes pour l'identification d'un bioagent |
| US9890408B2 (en) | 2009-10-15 | 2018-02-13 | Ibis Biosciences, Inc. | Multiple displacement amplification |
| US20130302369A1 (en) * | 2011-02-04 | 2013-11-14 | Omar Yousif Abdelmagid | Immunogenic Bordetella Bronchiseptica Compositions |
| AU2012213034B2 (en) * | 2011-02-04 | 2017-06-29 | Zoetis Services Llc | Compositions for canine respiratory disease complex |
| ITMI20111182A1 (it) * | 2011-06-28 | 2012-12-29 | Canio Buonavoglia | Vaccino per coronavirus canino |
| AU2013267716B2 (en) * | 2012-05-31 | 2018-03-08 | Zoetis Services Llc | Vaccination with Canine Respiratory Coronavirus for protection against B. bronchiseptica infections |
| CN105803112A (zh) * | 2016-03-28 | 2016-07-27 | 中国人民解放军成都军区疾病预防控制中心 | 用于检测犬细小病毒的引物、探针和试剂盒及检测方法 |
| CN108318685A (zh) * | 2018-05-04 | 2018-07-24 | 广州敏捷生物技术有限公司 | 用于检测犬冠状病毒抗原的免疫荧光层析检测卡与制备方法 |
| CN111254155A (zh) * | 2020-01-25 | 2020-06-09 | 王跃驹 | 一种植物作为宿主表达病毒疫苗的方法 |
| WO2021159648A1 (fr) * | 2020-02-10 | 2021-08-19 | 中国科学院微生物研究所 | Antigène du coronavirus bêta, son procédé de préparation et son utilisation |
| JP2023546076A (ja) * | 2020-10-08 | 2023-11-01 | コントロールポイント インコーポレイテッド | 呼吸器感染症を検出するための方法及び器具 |
| CN112094953B (zh) * | 2020-10-30 | 2022-11-11 | 内蒙古农业大学 | 用于同时检测牛病毒性腹泻病毒、牛轮状病毒和牛冠状病毒的试剂盒及引物和探针 |
| US11175293B1 (en) | 2021-01-04 | 2021-11-16 | University Of Utah Research Foundation | Rapid assay for detection of SARS-CoV-2 antibodies |
| CA3106787A1 (fr) * | 2021-01-22 | 2022-07-22 | Amphotericin B Technologies Inc. | Utilisation d'amphotericine b dans le traitement de maladies du coronavirus |
| CN116854784B (zh) * | 2023-09-05 | 2023-11-17 | 北京纳百生物科技有限公司 | 犬冠状病毒n蛋白抗原截短体及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4567043A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
| US5672350A (en) | 1989-08-22 | 1997-09-30 | Veterinary Infectious Disease Organization | Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines |
| NZ240558A (en) | 1990-11-14 | 1994-11-25 | Smithkline Beecham Corp | Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease |
| US6057436A (en) | 1990-11-14 | 2000-05-02 | Pfizer Inc. | Canine coronavirus S gene and uses therefor |
| US6372224B1 (en) | 1990-11-14 | 2002-04-16 | Pfizer Inc. | Canine coronavirus S gene and uses therefor |
| EP0510773B1 (fr) * | 1991-04-25 | 2003-12-17 | Akzo Nobel N.V. | Vaccin de sous-unités contre le coronavirus canin |
| DK0640098T3 (da) | 1992-05-08 | 2002-10-28 | Pfizer | S-gen fra hundecoronavirus og anvendelser deraf |
| US5750112A (en) | 1993-02-26 | 1998-05-12 | Solvay Animal Health, Inc. | Canine coronavirus vaccine from feline enteric coronavirus |
| EP0833903B1 (fr) * | 1995-06-12 | 2004-08-25 | Kansas State University Research Foundation | Nouveau vaccin multivalent a base de virus corona bovin et methode de traitement de l'infection au virus corona bovin |
| EP0934410A1 (fr) | 1996-10-11 | 1999-08-11 | Human Genome Sciences, Inc. | Inhibiteur cerebro-associe de l'activateur du plasminogene de type tissulaire |
| AU1408499A (en) | 1997-11-14 | 1999-06-07 | Thomas P. Brown | Compositions and methods to prevent turkey enteritis |
| US6974577B2 (en) * | 2001-02-04 | 2005-12-13 | Novartris Ag | Inactivated bovine scours vaccines, processes and method of preventing bovine scours |
-
2002
- 2002-07-27 GB GBGB0217434.0A patent/GB0217434D0/en not_active Ceased
-
2003
- 2003-07-01 NZ NZ537778A patent/NZ537778A/en not_active IP Right Cessation
- 2003-07-01 SI SI200331946T patent/SI1525313T1/sl unknown
- 2003-07-01 MX MXPA05001098A patent/MXPA05001098A/es active IP Right Grant
- 2003-07-01 AT AT03738299T patent/ATE491793T1/de active
- 2003-07-01 DK DK03738299.1T patent/DK1525313T3/da active
- 2003-07-01 US US10/522,513 patent/US7776340B2/en not_active Expired - Fee Related
- 2003-07-01 DE DE60335374T patent/DE60335374D1/de not_active Expired - Lifetime
- 2003-07-01 NZ NZ556442A patent/NZ556442A/en not_active IP Right Cessation
- 2003-07-01 ES ES03738299T patent/ES2384445T3/es not_active Expired - Lifetime
- 2003-07-01 EP EP09075521A patent/EP2182066A3/fr not_active Withdrawn
- 2003-07-01 CA CA2727782A patent/CA2727782C/fr not_active Expired - Fee Related
- 2003-07-01 CA CA2492333A patent/CA2492333C/fr not_active Expired - Fee Related
- 2003-07-01 EP EP03738299A patent/EP1525313B1/fr not_active Expired - Lifetime
- 2003-07-01 PT PT03738299T patent/PT1525313E/pt unknown
- 2003-07-01 WO PCT/GB2003/002832 patent/WO2004011651A1/fr not_active Ceased
- 2003-07-01 JP JP2004523905A patent/JP4644486B2/ja not_active Expired - Fee Related
- 2003-07-01 AU AU2003244822A patent/AU2003244822B2/en not_active Ceased
-
2005
- 2005-02-23 NO NO20050979A patent/NO20050979L/no not_active Application Discontinuation
-
2008
- 2008-09-26 US US12/239,527 patent/US7981427B2/en not_active Expired - Fee Related
-
2011
- 2011-02-14 CY CY20111100173T patent/CY1111655T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20070248616A1 (en) | 2007-10-25 |
| AU2003244822A1 (en) | 2004-02-16 |
| EP2182066A3 (fr) | 2010-08-11 |
| EP1525313B1 (fr) | 2010-12-15 |
| GB0217434D0 (en) | 2002-09-04 |
| DK1525313T3 (da) | 2011-03-14 |
| ATE491793T1 (de) | 2011-01-15 |
| US7776340B2 (en) | 2010-08-17 |
| NZ556442A (en) | 2009-03-31 |
| WO2004011651A1 (fr) | 2004-02-05 |
| CA2492333A1 (fr) | 2004-02-05 |
| CA2492333C (fr) | 2013-08-20 |
| JP4644486B2 (ja) | 2011-03-02 |
| US7981427B2 (en) | 2011-07-19 |
| SI1525313T1 (sl) | 2011-03-31 |
| NO20050979D0 (no) | 2005-02-23 |
| ES2384445T3 (es) | 2012-07-05 |
| CA2727782C (fr) | 2016-10-11 |
| CY1111655T1 (el) | 2015-10-07 |
| EP1525313A1 (fr) | 2005-04-27 |
| AU2003244822B2 (en) | 2009-01-29 |
| PT1525313E (pt) | 2011-03-14 |
| US20090081780A1 (en) | 2009-03-26 |
| JP2005533513A (ja) | 2005-11-10 |
| EP2182066A2 (fr) | 2010-05-05 |
| DE60335374D1 (en) | 2011-01-27 |
| CA2727782A1 (fr) | 2004-02-05 |
| NZ537778A (en) | 2008-04-30 |
| MXPA05001098A (es) | 2005-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20050979L (no) | Caninus respiratorisk coronavirus (CRCV) spike protein, polymerase og hemagglutinin/esterase | |
| CY1109848T1 (el) | Συστημα καταιονισμου/αναρροφησεως | |
| ES2524458T3 (es) | DNasa para el tratamiento de la subfertilidad masculina | |
| NO20074412L (no) | Bruddresistente administrasjonsformer med forsinket frigiving | |
| BRPI0408807A (pt) | sistema de fixação de fratura de osso com suporte de superfìcie articular e subcondral | |
| WO2006110738A3 (fr) | Systeme de vis de compression active et son procede d'utilisation | |
| CR8012A (es) | Clavo endomedular destinado al tratamiento de fracturas de femur proximal | |
| NZ707292A (en) | Activin-actrii antagonists and uses for increasing red blood cell levels | |
| WO2007109767A3 (fr) | Dispositif d'installation d'un ancrage osseux et méthode d'utilisation | |
| HRP20090245T1 (en) | Pyy agonists and uses thereof | |
| DE502005008015D1 (de) | Künstliches gelenkelement sowie ein damit ausgestattetes greifwerkzeug | |
| WO2008118524A3 (fr) | Système d'articulation instrumenté | |
| ATE392859T1 (de) | Wirbelsäulen-osteosynthesesystem | |
| WO2010074575A3 (fr) | Virus de la peste porcine classique (vppc) recombiné comprenant une protéine e2 modifiée et procédés de production dudit vppc recombiné | |
| DE602007001467D1 (de) | Therapeutische Zubereitung von hochreinem FVIIa und Verfahren zu dessen Gewinnung | |
| AU2003289631A8 (en) | A recombinant adenovirus relating gene vaccine used to therapy and prevent alzheimers disease, and use thereof | |
| ATE346552T1 (de) | Implantatsystem | |
| DE602004015772D1 (de) | Ein matrizenband | |
| WO2008029142A3 (fr) | Plaque vissée destinée à être fixée aux vertèbres d'un patient | |
| SG160327A1 (en) | Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds | |
| ATE392196T1 (de) | Chirurgisches instrument zum entfernen eines zwischenwirbelimplantats | |
| DE69835424D1 (de) | Boviner atmungs- und darmcoronavirus als impfstoff | |
| MX2009003976A (es) | Taladro para el uso en odontologia y con inercia modulada. | |
| WO2003086453A8 (fr) | Sous-fragment recodifie codant pour la neuro-aminidase, neuro-aminidase recombinante et sont utilisation en zooprophylaxie | |
| DK1532279T3 (da) | Fremgangsmåde, sammensætning og kit til antigenbinding af Norwalk-lignende vira |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |